Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Dec;160(6):1269-1275.e1.
doi: 10.1016/j.ajo.2015.08.032. Epub 2015 Sep 3.

Retinal Architecture in ​RGS9- and ​R9AP-Associated Retinal Dysfunction (Bradyopsia)

Affiliations
Case Reports

Retinal Architecture in ​RGS9- and ​R9AP-Associated Retinal Dysfunction (Bradyopsia)

Rupert W Strauss et al. Am J Ophthalmol. 2015 Dec.

Abstract

Purpose: To characterize photoreceptor structure and mosaic integrity in subjects with ​RGS9- and R9AP-associated retinal dysfunction (bradyopsia) and compare to previous observations in other cone dysfunction disorders such as oligocone trichromacy.

Design: Observational case series.

Methods: setting: Moorfields Eye Hospital (United Kingdom) and Medical College Wisconsin (USA).

Study population: Six eyes of 3 subjects with disease-causing variants in ​RGS9 or R9AP.

Main outcome measures: Detailed retinal imaging using spectral-domain optical coherence tomography and confocal adaptive-optics scanning light ophthalmoscopy.

Results: Cone density at 100 μm from foveal center ranged from 123 132 cones/mm(2) to 140 013 cones/mm(2). Cone density ranged from 30 573 to 34 876 cones/mm(2) by 600 μm from center and from 15 987 to 16,253 cones/mm(2) by 1400 μm from center, in keeping with data from normal subjects. Adaptive-optics imaging identified a small, focal hyporeflective lesion at the foveal center in both eyes of the subject with RGS9-associated disease, corresponding to a discrete outer retinal defect also observed on spectral-domain optical coherence tomography; however, the photoreceptor mosaic remained intact at all other observed eccentricities.

Conclusions: Bradyopsia and oligocone trichromacy share common clinical symptoms and cannot be discerned on standard clinical findings alone. Adaptive-optics imaging previously demonstrated a sparse mosaic of normal wave-guiding cones remaining at the fovea, with no visible structure outside the central fovea in oligocone trichromacy. In contrast, the subjects presented in this study with molecularly confirmed bradyopsia had a relatively intact and structurally normal photoreceptor mosaic, allowing the distinction between these disorders based on the cellular phenotype and suggesting different pathomechanisms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectral-domain optical coherence tomography B-scans in 3 subjects with bradyopsia. Top left: A representative macular line scan is shown with designated layer thickness measurements. Bottom left: Total retinal thickness was normal in all subjects compared to a normative database. Normative average thickness is shown as a black line ± 2 standard deviations (gray shaded region). Inner retinal thickness (Top right) and outer nuclear layer thickness (Bottom right) was within the normal range for all subjects compared to a normative database. Subject JC_0759 is represented by a triangle, MM_0032 as a square, and MM_0033 as a circle throughout.
Figure 2
Figure 2
Horizontal spectral-domain optical coherence tomography images through the fovea of all 3 bradyopsia subjects. Qualitative spectral-domain optical coherence tomography analysis shows a focal disruption in the inner segment ellipsoid and interdigitation zone in JC_0759 (Top). This contrasts to the intact outer retinal lamination present in MM_0032 (Middle) and MM_0033 (Bottom). The arrows on JC_0759 and MM_0033 indicate the location of the adaptive-optics scanning light ophthalmoscopy montage shown in Figure 3.
Figure 3
Figure 3
Foveal montages derived from adaptive-optics scanning light ophthalmoscopy for the RGS9 subject JC_0759 and R9AP subject MM_0033. The foveal montage for JC_0759 (Top) shows a hyporeflective lesion that corresponds to the disruption seen on spectral-domain optical coherence tomography in Figure 2. Conversely, the foveal montage from MM_0033 (Bottom) shows a qualitatively normal cone mosaic across the foveal region. Scale bar is 100 μm.
Figure 4
Figure 4
Photoreceptor images from multiple eccentricities obtained with adaptive-optics scanning light ophthalmoscopy in 2 bradyopsia patients. Photoreceptor images are shown at the center of peak density (lesion: JC_0759, Top row, and MM_0033, Bottom row), and 200, 400, 800, and 1200 μm away from center of peak density. Cone photoreceptors were readily identifiable at all locations except the center of JC_0759. Scale bar is 20 μm.
Figure 5
Figure 5
Cone photoreceptor density in relation to eccentricity in 3 subjects with bradyopsia. Normal cone density established by histologic analysis (Curcio and associates20) is shown as the gray shaded region. Subject JC_0759 is represented by a triangle, MM_0032 as a square, and MM_0033 as a circle. The 3 subjects with bradyopsia have very similar cone densities from 0.3 mm from peak density and thereby their respective symbols overlap.
Figure 6
Figure 6
Comparison of foveal cone mosaics as imaged by adaptive-optics light ophthaloscopy in normal subjects and subjects with oligocone trichromacy and RGS9/R9AP-associated retinopathy. Normal (Left) and RGS9/R9AP-associated retinopathy (Right) subjects have a continuous cone mosaic across the foveal region. In contrast, a decreased cone mosaic is observed in oligocone trichromacy (Middle). Scale bar is 25 μm.

Similar articles

Cited by

References

    1. Kooijman A.C., Houtman A., Damhof A., van Engelen J.P. Prolonged electro-retinal response suppression (PERRS) in patients with stationary subnormal visual acuity and photophobia. Doc Ophthalmol. 1991;78(3-4):245–254. - PubMed
    1. Nishiguchi K.M., Sandberg M.A., Kooijman A.C. Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation. Nature. 2004;427(6969):75–78. - PubMed
    1. Michaelides M., Li Z., Rana N.A. Novel mutations and electrophysiologic findings in RGS9- and R9AP-associated retinal dysfunction (Bradyopsia) Ophthalmology. 2010;117(1):120–127.e1. - PubMed
    1. Hartong D.T., Pott J.W., Kooijman A.C. Six patients with bradyopsia (slow vision): clinical features and course of the disease. Ophthalmology. 2007;114(12):2323–2331. - PubMed
    1. Aboshiha J., Dubis A.M., Carroll J. The cone dysfunction syndromes. Br J Ophthalmol. 2015 - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources